Kissei Pharmaceutical Co Ltd
TSE:4547
Operating Margin
Kissei Pharmaceutical Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| JP |
|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
158.4B JPY |
5%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
844.2B USD |
38%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
376.6B USD |
26%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
48%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
213.9B CHF |
33%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
190.6B CHF |
32%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
164.6B GBP |
23%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
214.2B USD |
35%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
118.1B EUR |
22%
|
Kissei Pharmaceutical Co Ltd
Glance View
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Kissei Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 4.9%.
You don't have any saved screeners yet